NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)

National Institutes of Health · HHS

CFDA Numbers

93.310

Award Ceiling

$475K

Award Floor

$475K

Expected Awards

Close Date

Aug 19, 2026

Section I

How to Apply

View on grants_gov ↗

Program Contact

NewInnovatorAwards@mail.nih.gov
Please contact via e-mail.

Section II

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government, excluding the NIH Intramural Research Program (NIH IRP);U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Eligible Applicant Types

00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25

Section III

Description

The NIH Director’s New Innovator Award supports early stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director’s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.

Section IV

Key Dates

Posted: Jun 19, 2026
Closes: Aug 19, 2026